Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA was delisted on the 18th of January, 2023.
11 hedge funds and large institutions have $22.3M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
57% more funds holding
Funds holding: 7 → 11 (+4)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
15% more capital invested
Capital invested by funds: $19.4M → $22.3M (+$2.89M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$4.76M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.55M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$500K |
| 4 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$214K |
| 5 |
Morgan Stanley
New York
|
+$59.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.25M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$661K |
| 3 |
Millennium Management
New York
|
-$124K |
AYLA Hedge Fund Activity: Q1 2021 in Review
11 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Ayala Pharmaceuticals, Inc. Common Stock (AYLA) for Q1 2021, worth a combined $22.3M — up 15% from $19.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AYLA positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Sio Capital Management, adding an estimated $4.76M. The largest seller was ARK Investment Management, exiting entirely with an estimated $1.25M sold.
- 11 institutional investors held Ayala Pharmaceuticals, Inc. Common Stock (AYLA) as of Q1 2021, up from 7 in Q4 2020.
- Funds reported $22.3M of Ayala Pharmaceuticals, Inc. Common Stock stock for Q1 2021, up 15% quarter-over-quarter.
- 5 funds opened new Ayala Pharmaceuticals, Inc. Common Stock positions in Q1 2021 and 1 closed out, a net change of +4 holders.
- The largest Ayala Pharmaceuticals, Inc. Common Stock buyer in Q1 2021 was Sio Capital Management, an estimated $4.76M added.
- The largest Ayala Pharmaceuticals, Inc. Common Stock seller in Q1 2021 was ARK Investment Management, an estimated $1.25M sold.
Based on aggregated 13F filings for Q1 2021.